EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay

Ryosuke Arata, Naoki Tanimine, Akhmet Seidakhmetov, Kentaro Ide, Yuka Tanaka, Hideki Ohdan

Transplant International · 2025

DOI: 10.3389/ti.2025.13879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2025. Verfasst von Ryosuke Arata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Skin Transplantation, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding donor-reactive T-cell behavior post-transplantation is challenging owing to the rarity and diversity of these cells. Here, we aimed to evaluate the relevance of an assay for rapidly detecting alloreactive T cells in a mouse transplantation model. After 18 h of one-way mixed lymphocyte reaction (MLR) culture with pre-activated donor-derived stimulators, CD4 + and CD8 + donor-reactive T cells were identified by CD154 and CD137 expression, respectively. Using full MHC mismatched mouse skin transplant models, we observed an increased donor-reactive T-cell proportion by direct presentation with elevated interferon gamma and granzyme B production 7 days post-transplantation, before graft rejection. Immunosuppression with CTLA-4 IgG and anti-CD154 antibody varied depending on donor-recipient strain combinations. On day 7, donor-reactive CD8 + T-cell proportions were lower in the tolerance model (BALB/c to C3H/HeJ) than in the rejection model (BALB/c to C57BL/6); conventional proliferation readout after 4 days of MLR could not distinguish these responses. Overall, although the conventional readout for evaluating T-cell proliferation following an MLR quantifies the precursor frequency of alloreactive T cells, the assay reported herein assesses T-cell activation markers after a short-term MLR to characterize immediate immune status. These findings offer a promising tool to elucidate immune responses post-transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin TransplantationCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesT-LymphocytesAnimalsMiceTransplantation, HomologousMice, Inbred C57BLGraft RejectionMice, Inbred C3HMice, Inbred BALB CLymphocyte Culture Test, MixedGranzymesCD40 LigandInterferon-gammaMaleTumor Necrosis Factor Receptor Superfamily, Member 9Lymphocyte Activation

Stichwörter der Autor:innen

allogeneic transplantationalloreactive T-cellimmune monitoringrejectiontolerance

Substanzen

GranzymesCD40 LigandInterferon-gammaTumor Necrosis Factor Receptor Superfamily, Member 9

Autor:innen und Institutionen

  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Zitieren

APA

Arata, R., Tanimine, N., Seidakhmetov, A., Ide, K., Tanaka, Y., & Ohdan, H. (2025). Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay. Transplant International. https://doi.org/10.3389/ti.2025.13879

Vancouver

Arata R, Tanimine N, Seidakhmetov A, Ide K, Tanaka Y, Ohdan H. Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay. Transplant International. 2025. doi:10.3389/ti.2025.13879

BibTeX
@article{Arata2025,
  author = {Arata, Ryosuke and Tanimine, Naoki and Seidakhmetov, Akhmet and Ide, Kentaro and Tanaka, Yuka and Ohdan, Hideki},
  title = {Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.13879}
}
Kostenlos starten →